Abbott Laboratories: Tailwind From Healthcare Spending And Emerging Markets
I have been a shareholder in Abbott Laboratories (ABT) since the acquisition of St. Jude in 2016. I believe this is a very good
Continue readingAnalysis and portfolios for rational investing
I have been a shareholder in Abbott Laboratories (ABT) since the acquisition of St. Jude in 2016. I believe this is a very good
Continue reading